Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees

被引:0
作者
N. Zander
I. Schäfer
M. Radtke
A. Jacobi
H. Heigel
M. Augustin
机构
[1] University Medical Center Hamburg-Eppendorf,German Center for Health Services Research in Dermatology (CVderm), Institute for Health Services Research in Dermatology and Nursing (IVDP)
[2] Heigel GmbH,undefined
来源
Archives of Dermatological Research | 2017年 / 309卷
关键词
Psoriasis; Comorbidities; Need for treatment; Epidemiology; Prevalence rates;
D O I
暂无
中图分类号
学科分类号
摘要
The field of dermatological comorbidity in psoriasis is only passively explored with contradictory results. Objective of this study was to further investigate the complex field of psoriasis and associated skin diseases by identifying skin comorbidity patterns in an extensive cohort of employees in Germany. Retrospective analysis of data deriving from occupational skin cancer screenings was conducted. From 2001 to 2014 German employees between 16 and 70 years from different branches underwent single whole-body screenings by trained dermatologists in their companies. All dermatological findings and need for treatment were documented. Point prevalence rates and their 95% confidence intervals were computed. Logistic regression analysis was performed to calculate odds ratios (OR) of single dermatological diseases to occur together with psoriasis controlled for age and sex. Data from 138,930 persons (56.5% male, mean age 43.2) were evaluated. Psoriasis point prevalence was 2.0%. Of those 20.6% had unmet treatment needs of their disease. Onychomycosis was the most frequent dermatological comorbidity with a prevalence of 7.8%. Regression analysis found rosacea (OR = 1.40, 95% CI 1.13–1.72) and telangiectasia (OR = 1.25, 95% CI 1.10–1.41) to be significantly associated with psoriasis. 17.2% of psoriasis patients had at least one further finding requiring treatment. The highest treatment needs were found for onychomycosis (3.4%), tinea pedis (3.1%), and verruca plantaris (1.0%). It can be concluded that persons with psoriasis are at increased risk to suffer from comorbid skin diseases, which should be considered in treatment regimens. Particular attention should be paid to fungal diseases of the feet.
引用
收藏
页码:349 / 356
页数:7
相关论文
共 121 条
[31]  
Radtke MA(2009)Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis Br J Dermatol 16 300-305
[32]  
Zander N(2012)The coexistence of psoriasis and vitiligo: a review J Cutan Med Surg 217 169-172
[33]  
Hamnerius N(2008)Prevalence of skin diseases in a cohort of 48,665 employees in Germany Dermatology 73 308-313
[34]  
Berglund J(2011)Epidemiologie der Psoriasis in Deutschland-Auswertung von Sekundärdaten einer gesetzlichen Krankenversicherung Gesundheitswesen 122 261-266
[35]  
Faergemann J(2008)Antimicrobial peptides and the skin immune defense system J Allergy Clin Immunol 8 135-143
[36]  
Henseler T(2008)The role of antimicrobial peptides in human skin and in skin infectious diseases Infect Disord Drug Targets 56 466-472
[37]  
Christophers E(2005)Psychosocial consequences of psoriasis—an empirical study on the burden of skin disease in 3753 patients Hautarzt 227 311-315
[38]  
Klaassen KMG(2013)Comorbidities associated with vitiligo: a ten-year retrospective study Dermatology 73 856-863
[39]  
Dulak MG(2015)Role of sebaceous glands in inflammatory dermatoses J Am Acad Dermatol 221 229-235
[40]  
van de Kerkhof PCM(2010)Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730 Dermatology 142 1279-1284